Evotec SE (ETR:EVT - Get Free Report) dropped 1.3% during mid-day trading on Thursday . The company traded as low as €6.30 ($6.84) and last traded at €6.32 ($6.86). Approximately 509,397 shares were traded during trading, a decline of 63% from the average daily volume of 1,360,000 shares. The stock had previously closed at €6.40 ($6.95).
Evotec Stock Down 1.2 %
The firm has a market cap of $1.11 billion, a P/E ratio of -6.49, a price-to-earnings-growth ratio of 0.98 and a beta of 1.05. The firm's 50-day simple moving average is €7.72 and its 200 day simple moving average is €7.64.
About Evotec
(
Get Free Report)
Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas, such as autoimmune diseases, cancer, CNS diseases, diabetes, fibrosis, immunology, infectious diseases, kidney diseases, liver diseases, pain and inflammation, rare diseases, respiratory diseases, tuberculosis, and women's health.
Featured Articles
Before you consider Evotec, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Evotec wasn't on the list.
While Evotec currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
